183 related articles for article (PubMed ID: 38317799)
21. Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
Dai P; Wang Q; Jia M; Leng Z; Xie S; Feng L; Yang W
Hum Vaccin Immunother; 2023 Dec; 19(1):2194190. PubMed ID: 37099400
[TBL] [Abstract][Full Text] [Related]
22. Defining drivers of under-immunization and vaccine hesitancy in refugee and migrant populations.
Deal A; Crawshaw AF; Carter J; Knights F; Iwami M; Darwish M; Hossain R; Immordino P; Kaojaroen K; Severoni S; Hargreaves S
J Travel Med; 2023 Sep; 30(5):. PubMed ID: 37335192
[TBL] [Abstract][Full Text] [Related]
23. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas.
Ropero Álvarez AM; Pérez-Vilar S; Pacis-Tirso C; Contreras M; El Omeiri N; Ruiz-Matus C; Velandia-González M
BMC Public Health; 2017 Apr; 17(1):325. PubMed ID: 28415981
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey.
Huang Y; Su X; Xiao W; Wang H; Si M; Wang W; Gu X; Ma L; Li L; Zhang S; Yang C; Yu Y; Qiao Y
BMC Infect Dis; 2022 Feb; 22(1):153. PubMed ID: 35164700
[TBL] [Abstract][Full Text] [Related]
25. Association between timely initiation of hepatitis B vaccine and completion of the hepatitis B vaccine and national immunization program vaccine series.
Wu JN; Li DJ; Zhou Y
Int J Infect Dis; 2016 Oct; 51():62-65. PubMed ID: 27592194
[TBL] [Abstract][Full Text] [Related]
26. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
27. The National Task Force on Hepatitis B Immunization, Focus on Asians and Pacific Islanders: a chronicle of achievement.
Reilley BA
Asian Am Pac Isl J Health; 2001; 9(2):112-37. PubMed ID: 11858145
[TBL] [Abstract][Full Text] [Related]
28. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
Liu J; Liu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
[TBL] [Abstract][Full Text] [Related]
29. The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review.
Jiang M; Chen S; Yan X; Ying X; Tang S
Infect Dis Poverty; 2023 Dec; 12(1):114. PubMed ID: 38062480
[TBL] [Abstract][Full Text] [Related]
30. Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia.
Sinuraya RK; Nuwarda RF; Postma MJ; Suwantika AA
Global Health; 2024 Feb; 20(1):11. PubMed ID: 38321478
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.
Wiesen E; Lagani W; Sui G; Arava J; Reza S; Diorditsa S; Lin YC
Vaccine; 2016 Jan; 34(3):367-72. PubMed ID: 26620839
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
Constable C; Caplan A
Vaccine; 2020 Jan; 38(5):954-962. PubMed ID: 31843271
[TBL] [Abstract][Full Text] [Related]
33. Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China.
Ji M; Huang Z; Ren J; Wagner AL
Hum Vaccin Immunother; 2022 Nov; 18(5):2043025. PubMed ID: 35321621
[TBL] [Abstract][Full Text] [Related]
34. Overview of the United States' Immunization Program.
Roper L; Hall MAK; Cohn A
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S443-S451. PubMed ID: 34590134
[TBL] [Abstract][Full Text] [Related]
35. Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study.
Guan TH; Htut HN; Davison CM; Sebastian S; Bartels SA; Aung SM; Purkey E
PLoS One; 2021; 16(12):e0261470. PubMed ID: 34928996
[TBL] [Abstract][Full Text] [Related]
36. Mandatory vaccination of infants in France: Is that the way forward?
Partouche H; Gilberg S; Renard V; Saint-Lary O
Eur J Gen Pract; 2019 Jan; 25(1):49-54. PubMed ID: 30672344
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project P.R. China].
Cui FQ; Gong XH; Chen YS
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):289-93. PubMed ID: 20077723
[TBL] [Abstract][Full Text] [Related]
38. The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy.
Chen S; Zhao Y; Yang Z; Li Y; Shi H; Zhao T; Yang X; Li J; Li G; Wang J; Ying Z; Yang J
Hum Vaccin Immunother; 2022 Dec; 18(1):2024063. PubMed ID: 35044877
[TBL] [Abstract][Full Text] [Related]
39. Delays in routine childhood vaccinations and their relationship with parental vaccine hesitancy: a cross-sectional study in Wuxi, China.
Wang Q; Xiu S; Yang L; Han Y; Huang J; Cui T; Shi N; Liu M; Wang X; Lu B; Jin H; Lin L
Expert Rev Vaccines; 2022 Jan; 21(1):135-143. PubMed ID: 34789062
[TBL] [Abstract][Full Text] [Related]
40. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
De Waure C; Sisti LG; Poscia A; Ricciardi W
Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
